EPIX: ESSA Pharma Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 72.35
Enterprise Value ($M) -20.96
Book Value ($M) 118.77
Book Value / Share 2.68
Price / Book 0.61
NCAV ($M) 118.24
NCAV / Share 2.66
Price / NCAV 0.61

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 33.12
Current Ratio 33.12

Balance Sheet (mrq) ($M)
Current Assets 122.11
Assets 122.63
Liabilities 3.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -34.42
Net Income -28.54

Cash Flow Statement (mra) ($M)
Cash From Operations -22.72
Cash from Investing 91.79
Cash from Financing 0.93

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Rtw Investments, Lp 2.50 -65.87
02-14 13G/A BML Investment Partners, L.P. 9.40 0.00
02-14 13G/A PFM Health Sciences, LP 0.00
02-11 13G/A Soleus Capital, LLC 5.10 -47.73
11-14 13G/A Bb Biotech Ag 0.00 -100.00
11-08 13D Tang Capital Management Llc 9.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-12-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 11,899 169,957 7.00
2025-03-13 4,752 88,352 5.38
2025-03-12 9,319 30,857 30.20
2025-03-11 10,088 81,560 12.37
2025-03-10 2,603 111,566 2.33

(click for more detail)

Similar Companies
ENTO – Entero Therapeutics, Inc. ENTX – Entera Bio Ltd.
ENVB – Enveric Biosciences, Inc. EQ – Equillium, Inc.
ERNA – Eterna Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io